Views & Analysis Will plausibility reign supreme in Lyrica second medical use... Pharma needs clarity from the Supreme Court on whether the whole scope of a patent claim must be plausible at the time of the application.
Events Partner Content 2018 Off-Label Regulatory Compliance Congress Explore the Ever-Changing Regulatory Landscape
Events Partner Content Responding to the Opioid Crisis: Litigation, Regulation &... There are numerous pharmaceutical and plaintiff conferences on the opioid crisis, but none that cover the legal and regulatory aspects from BOTH sides of litigation.
News Tenax trounced by phase 3 heart failure readout Shares in Tenax 85% of their value after its drug for patients with pulmonary hypertension caused by a form of heart failure flunked a phase 3 trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
